Mon 20 July 2020:
Russia hopes to complete trials of a vaccine in August and produce 200 million doses with foreign partners by the end of the year, the head of its sovereign wealth fund has said.
The Russian Direct Investment Fund (RDIF), which manages some $10bn, is working with a government research institute on one of several vaccine projects in the country.
“Immediately after that we are planning to begin mass production,” Dmitriev said in a statement on Russia’s state anti-coronavirus portal.
“Mass production of this vaccine can stop the pandemic’s potential ‘second wave’,” he said, adding that Russia would be in a position to produce 30 million doses of the vaccine by year’s end, with “international partners across the world” joining in to bring the total to 200 million.
Think your friends would be interested? Share this story!
